MedTrace Logo

Safety Planning Intervention to Reduce Short Term Risk

NCT03227991 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 422

Last updated 2024-01-05

No results posted yet for this study

Summary

This study will determine the efficacy of Safety Planning Intervention (SPI) compared to receiving risk factors and warning sign information (RWI) in recent suicide attempters during the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental health/substance use treatment engagement; (3) suicide-related coping strategies; (4) suicidal ideation; and (5) use of means restriction.

Conditions

  • Suicide, Attempted

Interventions

BEHAVIORAL

Safety Planning Intervention

The Safety Planning Intervention is a protocol driven, brief suicide prevention strategy that is a good fit for acute care settings. It involves a clinician working collaboratively with the patient to build a personalized safety plan that is documented using a templated paper form and includes warning sign identification, means restriction and personalized strategies to deescalate a suicide crisis.

BEHAVIORAL

Risk factors and Warning signs

Printed information sheet listing suicide risk factors and crisis hotlines

Sponsors & Collaborators

  • University of Pennsylvania

    collaborator OTHER

  • University of Massachusetts, Worcester

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • American Foundation for Suicide Prevention

    collaborator OTHER

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Barbara H Stanley, Ph.D. · New York State Psychiatric Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-10
Primary Completion
2020-01-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03227991 on ClinicalTrials.gov